Encompass Health Corporation EHC
Set alert
137.19 USD +1.29 +0.95%
At close
136.68 -0.51 -0.37%
Pre-market · Nov 3, 7:58 AM ET
134.58 Day range 138.35
92.77 52-week range 138.35
- YTD
- +29.25%
- 1 year
- +20.50%
- Open
- 136.31
- Prev close
- 135.90
- Mkt cap
- 13.49B
- Vol
- 1.58M
- Avg vol
- 1.01M
- EPS
- 6.25
- P/E
- 21.95
- Div yield
- 0.64%
More statistics
- Low
- 134.58
- High
- 138.35
- Forward P/E
- 19.95
- Beta
- 0.67
- Short ratio
- 3.47
- Inst. own
- 101.00%
- Dividend
- 0.84
- Ex-div date
- Jan 3, 2027
- Earnings
- Feb 4, 2027
- 50-d avg
- 122.85
- 200-d avg
- 110.05
- 1y target
- 154.83
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 154.83 +12.9% upside
Now 137.19
- Target (low)
- 140.00
- Target (mean)
- 154.83
- Target (high)
- 177.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy1
- Buy12
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.63 | 1.57 – 1.66 | 1.46 | +11.5% | 1.68B | +8.9% | 11 |
| Next quarter | 1.70 | 1.62 – 1.75 | 1.60 | +6.3% | 1.71B | +8.0% | 8 |
| Current year | 6.29 | 6.23 – 6.33 | 5.45 | +15.5% | 6.48B | +9.1% | 12 |
| Next year | 6.88 | 6.15 – 7.11 | 6.29 | +9.3% | 7.02B | +8.4% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 30, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Oct 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 10, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | UBS | Maintained | Buy | Buy |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 28, 2026 | TD Cowen | Initiated | — | Buy |
| May 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 2, 2025 | UBS | Maintained | Buy | Buy |
| Sep 16, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 14, 2025 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2025 | UBS | Maintained | Buy | Buy |
| Jun 5, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 27, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Apr 28, 2025 | UBS | Maintained | Buy | Buy |
| Apr 28, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 28, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Apr 25, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Apr 25, 2025 | Barclays | Maintained | Overweight | Overweight |
| Feb 11, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Feb 10, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Feb 7, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2024 | Truist Securities | Reiterated | Buy | Buy |
